Repeated dose toxicity
| Current effective version |
|
| Reference number | CPMP/SWP/1042/99 Rev. 1 Corr. |
| Published | 29/03/2010 |
| Effective from | 01/09/2010 |
| Keywords | Repeated dose toxicity, study design, choice of species, list of tissues |
| Description | This document applies to the conduct of repeated dose toxicity studies of active substances intended for human use. It provides guidance on the choice of animal species, the size of groups, animal husbandry and parameters to be monitored during the in-life phase of a study. |
Document history
Revision 1 Current version |
| In operation: 01/09/2010–present
Published: 29/03/2010
Published: 21/02/2008 |
| First version |
 Adopted guideline
| In operation: 01/10/2008–31/08/2010 |
Related content
- Evaluation of control samples for non-clinical safety studies: checking for contamination with the test substance
- ICH M3 (R2) Non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals
- ICH Q3A (R2) Impurities in new drug substances
- ICH Q3B (R2) Impurities in new drug products
- ICH S3A Toxicokinetics: the assessment of systemic exposure in toxicity studies
- ICH S4 Duration of chronic toxicity testing in animals (rodent and non-rodent toxicity testing)
- ICH S5 (R2) Reproductive toxicology: detection of toxicity to reproduction for medicinal products including toxicity to male fertility
- ICH S8 Immunotoxicity studies for human pharmaceuticals
- Non-clinical local tolerance testing of medicinal products